Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Sterculia villosa and Vernonia patula show potential as antioxidants.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

The KRTAP21-1 gene affects wool yield and can help improve wool production.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Kūlaris improved quality of life for acne sufferers without side effects.

Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.

Low input with cover crop optimizes yield and reduces greenhouse gas emissions.

The assay effectively detects hormonal activity of certain chemicals.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

A traditional herbal mix from East Nusa Tenggara may help hair regrowth after chemotherapy.

Certain gene variants are linked to a higher risk of polycystic ovary syndrome, hair loss, and obesity in women from western Saudi Arabia.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.